What is the purpose of the Triple Screen test?

The Triple Screen test is a prenatal blood test designed to evaluate the risk of certain chromosomal abnormalities, specifically Down Syndrome (Trisomy 21) and Trisomy 18. This test combines three specific markers—alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and estriol levels—into one assessment to provide information about the likelihood of these disorders being present in the fetus.

The importance of this test lies in its ability to screen for these genetic conditions early in pregnancy, allowing for further diagnostic testing if necessary. By identifying pregnancies at increased risk for these anomalies, healthcare providers can prepare for appropriate management and counseling for the parents. The significance of detecting these conditions through the Triple Screen test enhances overall prenatal care by providing expectant parents with valuable information about the health of their developing child.